How did AirSculpt Technologies (NASDAQ:AIRS) perform in Q4 and full-year 2025?

AirSculpt reported Q4 revenue of $33.4 million and full-year revenue of $151.8 million. Despite the top-line figures, the company posted a full-year net loss of $11.7 million. While the company maintained a positive adjusted EBITDA of $15.1 million for the year, the overall bottom line was pressured by declining procedure volumes and high debt servicing costs.

What happened to AirSculpt’s (NASDAQ:AIRS) case volumes in 2025?

The company saw a notable decline in procedure demand, with Q4 case volumes dropping 15% year-over-year to 2,604 procedures. For the full year, case volume fell 10.7% to 11,852 procedures. This downward trend suggests that high-ticket elective body contouring services may be facing headwinds from tightening consumer discretionary spending or increased competition in the aesthetics market.

What is the current debt and cash position for AirSculpt (NASDAQ:AIRS)?

As of December 31, 2025, AirSculpt held $8.4 million in cash against a substantial gross debt of $56 million. To address this leverage, the company utilized an "at-the-market" (ATM) equity offering after the year-end to raise $14.8 million. This capital injection allowed the company to reduce its gross debt to approximately $45 million, slightly improving its balance sheet flexibility.

What does the "at-the-market" (ATM) offering mean for existing AIRS shareholders?

The $14.8 million ATM offering resulted in the issuance of new shares, which typically dilutes the ownership percentage of existing shareholders. While this move provided essential cash to pay down $11 million in debt, it can put downward pressure on the share price in the short term. Investors often view this as a necessary trade-off to avoid more expensive debt financing or a potential liquidity crunch.

What is the revenue and EBITDA guidance for AirSculpt (NASDAQ:AIRS) in 2026?

For fiscal 2026, AirSculpt expects revenue to land between $151 million and $157 million, suggesting a flat to slightly positive growth trajectory compared to 2025. The company also forecasted adjusted EBITDA between $15 million and $17 million. This conservative guidance indicates that management expects a stabilization of the business rather than a rapid V-shaped recovery in procedure volumes.

Technology

Image for illustrative purposes only. Not a real photo.

AirSculpt Technologies reports $151.8M fiscal 2025 revenue

Written by Mahathir BayenaPublished Apr 2, 2026, 12:00 AMLast Updated Jul 6, 2026, 10:30 AM

AirSculpt Technologies (NASDAQ:AIRS), a national provider of body contouring procedures, reported its fourth-quarter and full-year fiscal 2025 financial results.

Fourth-quarter revenue totaled $33.4 million, while full-year revenue reached $151.8 million.

Case volume decreased approximately 15% year-over-year to 2,604 procedures in the fourth quarter and 11,852 procedures for the full year.

For the full year, adjusted EBITDA was $15.1 million and the net loss was $11.7 million.

As of December 31, 2025, the company held $8.4 million in cash with gross debt of approximately $56 million.

Subsequent to year-end, AirSculpt raised $14.8 million through an at-the-market (ATM) equity offering and reduced debt to approximately $45 million.

Looking ahead, the company provided fiscal 2026 guidance expecting revenue between $151 million and $157 million and adjusted EBITDA between $15 million and $17 million.

AirSculpt Technologies reports $151.8M fiscal 2025 revenue

Perguntas frequentes

Ativos relacionados a notícia